Spring Bloom begins in Phantasy Star Online 2 New Genesis, with of course, seasonal Rappies. The update adds rewards, new ...

• Experts fault policy design, cost-benefit analysis • Old projects discontinued after 2023 • NRC earns paltry N17 billion in ...

Pakistan State Oil’s (PSX: PSO) 1HFY26 results reflect a familiar PSO pattern: earnings resilience supported by finance-cost relief, while core operating performance remains under pressure from weaker ...

Pakistan State Oil (PSO), the nation’s energy flagship, recorded a profit-after-tax (PAT) of Rs12.1 billion for the first half of the fiscal year (1HFY26) ended December 31, 2025, registering an ...

Character customization has become a bullet point for most modern games, and for good reason. Player expression is one of the strongest ways to capture interest in the long term. Usually, though, it’s ...

Super Bowl LX began as a defensive battle, which was great news for those out there who expected low stat numbers for offensive players. But stats aren't final until they're final. You never know who ...

In the upcoming week, investor attention will focus on fallout from the Supreme Court's tariff ruling, tensions in Iran, and ...

San Antonio Spurs All-Star center Victor Wembanyama went off against the Los Angeles Lakers on Tuesday, Feb. 10 at Crypto.com Arena in downtown Los Angeles. Wembanyama dropped a Spurs-record 37 points ...

Anyone who put anything on rebounds just had a very bad time. No player on either team produced more than three. Totals started at 4+. Victor Wembanyama's three with a chance to tie at the buzzer ...

Team USA men's hockey enters the 2026 Milan Cortina Olympics with a real chance to win the gold medal for the first time since 1980, and it started on Thursday with a Group C game against Latvia. The ...

NHL.com's fantasy staff continues to cover the latest trends and storylines in the League through the lens of NHL EDGE puck and player tracker stats. Today, we look at the early impact of forward Tage ...

U.S. FDA Approves Bristol Myers Squibb’s Sotyktu® (deucravacitinib) for the Treatment of Adults with Active Psoriatic Arthritis ...